<b>Conclusions:</b> The study indicates the promising role of serum Sestrin 2 levels as a valuable biomarker for early diagnosis of endometrial polyps and uterine leiomyomas, advocating for further research into its diagnostic and therapeutic potential. Here, SESN2 is linked to Uterine leiomyoma.